Ensign Peak Advisors
AMTI

Ensign Peak Advisors’s Applied Molecular Transport Inc. Common Stock AMTI Stock Holding History

Ensign Peak Advisors’s Portfolio AMTI Stock Details AMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,430
Closed -$4K – 2373
2022
Q2 		$4K Hold
1,430
– – ﹤0.01% 2158
2022
Q1 		$11K Hold
1,430
– – ﹤0.01% 2188
2021
Q4 		$20K Buy
+1,430
New +$28.2K ﹤0.01% 2182

Other funds holding AMTI

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ensign Peak Advisors's AMTI Position: Q3 2022 in Review

Ensign Peak Advisors sold out of Applied Molecular Transport Inc. Common Stock (AMTI) in Q3 2022, closing a stake of 1,430 shares — an estimated $4K sold.

Ensign Peak Advisors first reported a position in AMTI in Q4 2021 and held it in 3 quarters. The position peaked at $20K in Q4 2021. 49 funds tracked by Wall St. Rank hold AMTI as of Q3 2022.

  • Ensign Peak Advisors reported no remaining Applied Molecular Transport Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 1,430 Applied Molecular Transport Inc. Common Stock shares in Q3 2022, an estimated $4K.
  • Ensign Peak Advisors first reported a position in Applied Molecular Transport Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Ensign Peak Advisors's Applied Molecular Transport Inc. Common Stock position peaked at $20K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Applied Molecular Transport Inc. Common Stock as of Q3 2022.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.